| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
Nasdaq: SFMT |
| Security Type |
Common Stock |
| Lead Underwriter |
Citigroup JP Morgan |
| Days In Registration |
120 |
| Date Filed |
21-Sep-2006 |
| Form Filed | S-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Manufacture medical devices that serves as novel treatments for degenerative spinal disorders worldwide, focused in the development and marketing of motion-preserving technologies and procedures for orthopedic and neurological spine surgery |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
- |
| Contact |
- |
| Number of Employees |
57 |
|
| Original Filing Information |
| US |
| Shares Filed |
- |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
- |
| File Amount |
- |
| File Price Range |
- - - |
| File Mid Price |
- |
|
